Recent Quotes (30 days)

You have no recent quotes
chg | %

Cangene Corporation news

Showing stories 1 - 10 of about 71   

Articles published

CNJ 0.0000
price chart
Cangene To Be Acquired By Emergent BioSolutions For US$222 Million
11, 2013 /CNW/ - Cangene Corporation ("Cangene") (TSX: CNJ) today announced the signing of a definitive agreement under which Emergent BioSolutions ("Emergent") (NYSE: EBS) of Rockville, Maryland will acquire Cangene in an all-cash transaction ...
Related articles »  
Cangene bought by US rival for $236-million, latest Canadian biotech taken private
Another of Canada's small biotechnology companies is disappearing from the public markets, with the proposed acquisition of Winnipeg-based Cangene Corp. by a U.S. rival. Emergent BioSolutions of Rockville, Maryland, has signed a deal to buy Cangene ...
Emergent BioSolutions pays $222M to acquire life sciences firm Cangene Corp.  Washington Post
Cangene to be acquired by Emergent BioSolutions
Related articles »  
Cangene takeover might not be a bad thing
One of the facts of life in the global economy is commercial ownership of assets is going to be bought and sold throughout that global marketplace.
Related articles »  
Emergent BioSolutions Completes Acquisition of Cangene Corporation
ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of Cangene Corporation for $222 million in cash. After payment by Cangene of transaction related costs, Emergent expects ...
Related articles »  
Ipsen and Inspiration Biopharmaceuticals Announce Closing of the IB1001 Sale ...
Ipsen (Paris:IPN) (Euronext: IPN; ADR: IPSEY) and Inspiration Biopharmaceuticals Inc. (Inspiration) today announced the closing of the sale of the proprietary hemophilia B product, IB1001 (recombinant FIX), to Cangene Corporation (TSX: CNJ) (Cangene).
Related articles »  
BALTIMORE AND WINNIPEG, May 2 /PRNewswire/ - Cangene Corporation's Baltimore-based injectable pharmaceutical contract-manufacturing subsidiary, Cangene bioPharma, Inc., has completed a US$11-million renovation of its sterile filling and support ...
Cangene Names John A. Sedor as President and Chief Executive Officer
16, 2011 /PRNewswire/ - Cangene Corporation (TSX: CNJ), a biopharmaceutical company primarily focused on specialty plasma products, today announces that its board of directors has unanimously appointed John A. Sedor as president and chief executive ...
Emergent BioSolutions Announces Executive Management Team of New Spin-Off ...
Mr. Lamothe assumed this role in 2014 when Emergent concluded the acquisition of Cangene Corporation, where he was Chief Financial Officer.
Kane Biotech Announces New Chief Financial Officer
Mr. Dupuis has more than 25 years of financial leadership experience across a broad range of industries including 15 years at Cangene Corporation, a former Canadian TSX-traded biotechnology company, where he progressed to the role of Senior Director ...
FDA approves treatment for inhalation anthrax
The product is manufactured by Cangene Corporation, based in Winnipeg, Canada. It was developed with support from BARDA within HHS' Office of the Assistant Secretary for Preparedness and Response.